Moxetumomab pasudotox and Reserpine, hydralazine, and hydrochlorothiazide
Determining the interaction of Moxetumomab pasudotox and Reserpine, hydralazine, and hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: hydralazine / hydrochlorothiazide / reserpine
Brand name:
Synonyms: Reserpine, hydralazine, and hydrochlorothiazide (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Resinol topical
- Moxetumomab pasudotox-Resorcinol and sulfur Topical
- Moxetumomab pasudotox-Resorcinol topical
- Moxetumomab pasudotox-Respaire-30
- Moxetumomab pasudotox-Resperal-DM Drops
- Moxetumomab pasudotox-Respi-TANN
- Reserpine, hydralazine, and hydrochlorothiazide-Moxetumomab Pasudotox-tdfk
- Reserpine, hydralazine, and hydrochlorothiazide-Moxetumomab pasudotox-tdfk Intravenous
- Reserpine, hydralazine, and hydrochlorothiazide-Moxifloxacin
- Reserpine, hydralazine, and hydrochlorothiazide-Moxifloxacin (Systemic)
- Reserpine, hydralazine, and hydrochlorothiazide-Moxifloxacin Hydrochloride
- Reserpine, hydralazine, and hydrochlorothiazide-Moxifloxacin Injection